NAYA Biosciences's market cap is currently $2.69M. The company's EPS TTM is $-2.544; its P/E ratio is ―; NAYA Biosciences is scheduled to report earnings on April 22, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.02M	$ 822.20K	$ 4.16M	$ 1.04M	$ 1.48M
Gross Profit	$ 1.09M	$ -28.57K	$ 4.02M	$ 948.53K	$ 1.34M
Operating Income	$ -6.77M	$ -10.63M	$ -5.22M	$ -5.51M	$ -1.79M
EBITDA	$ -6.88M	$ -10.75M	$ -5.22M	$ -5.48M	$ -1.76M
Net Income	$ -8.03M	$ -10.89M	$ -6.65M	$ -8.35M	$ -2.17M
Balance Sheet
Cash & Short-Term Investments	$ 232.42K	$ 90.14K	$ 5.68M	$ 10.10M	$ 1.24M
Total Assets	$ 18.51M	$ 3.71M	$ 10.47M	$ 10.95M	$ 1.80M
Total Debt	$ 6.30M	$ 2.27M	$ 2.12M	$ 775.02K	$ 457.47K
Net Debt	$ 6.07M	$ 2.18M	$ -3.56M	$ -9.32M	$ -781.12K
Total Liabilities	$ 17.61M	$ 4.69M	$ 3.16M	$ 5.20M	$ 5.51M
Stockholders' Equity	$ 892.83K	$ -977.61K	$ 7.31M	$ 5.74M	$ -3.71M
Cash Flow
Free Cash Flow	$ -5.20M	$ -6.62M	$ -6.48M	$ -4.86M	$ 1.31M
Operating Cash Flow	$ -4.76M	$ -6.60M	$ -6.03M	$ -4.78M	$ 1.37M
Investing Cash Flow	$ -2.49M	$ -81.22K	$ -2.15M	$ -187.25K	$ -114.71K
Financing Cash Flow	$ 7.39M	$ 1.09M	$ 3.77M	$ 13.82M	$ -229.47K

Currency in USD

NAYA Biosciences Earnings and Revenue History

Income Statement >

NAYA Biosciences Debt to Assets

Balance Sheet >

NAYA Biosciences Cash Flow

Cash Flow >

NAYA Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing